Shanghai, China

Yong Cang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Yong Cang - Innovator in Antibody-Drug Conjugates

Introduction

Yong Cang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biochemistry, particularly in the development of linkers for antibody-drug conjugates (ADCs). His innovative work focuses on enhancing cancer treatment through advanced drug delivery systems.

Latest Patents

Yong Cang holds 1 patent related to his invention titled "Linkers and their application towards ADC." This invention pertains to linkers that contain amide surrogates with a regular or novel lysosomal enzymatic cleavable dipeptidic unit. These linkers are designed to connect cytotoxic drugs to antibodies, thereby improving the efficacy of cancer treatments.

Career Highlights

Cang is currently associated with Medshine Discovery Inc., where he continues to push the boundaries of innovation in drug development. His work is pivotal in the creation of ADCs derived from amide surrogate linkers, which are crucial for targeted cancer therapies.

Collaborations

Yong Cang collaborates with notable colleagues, including Chun Sing Li and Jian Li. Their combined expertise contributes to the advancement of research and development in the field of biopharmaceuticals.

Conclusion

Yong Cang's contributions to the field of antibody-drug conjugates exemplify the impact of innovative thinking in cancer treatment. His work continues to inspire advancements in biochemistry and drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…